Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

IN8bio

Youtube Subscribe

...

Ticker: INAB

Sector: Biotechnology

IN8bio, inc. (inab) stock price, quote & news - stock analysis. IN8abio, Inc. (INAB) stock. price, quotes & news. stock analysis. INAB announces publication.
...
...
Extended Summary

IN8bio

IN8bio, inc. (inab) stock price, quote & news - stock analysis. IN8abio, Inc. (INAB) Stock Price, Quote & News - Stock Analysis. IN8bio Inc (INAB) Stock News | Stock Titan STOCK Titan: Inab (INab) stock news | stock titan. IN8bio announces publication on novel gamma-delta t cell therapy for glioblastoma in frontiers in immunology. The publication, titled: “ Adoptive cell therapy. for high grade gliomas using simultaneous temozolomide and intracranial mgmt-modified γδ t cells. IN8bio, Inc. (NASDAQ: INAB) Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology February 14, 2024 BioTech. In8bio, a clinical-stage biopharmaceutical company, focuses on gamma-delta T cell product candidates for solid tumors.

Related Results

...
February 26, 2024 20:40 (London Time)

IN8bio

IN8bio to present at upcoming investor conferences in March 24, 2024 at 4:00 p.m. ET on March 28, 2024. A live webcast and replay will be available …
Sector: Biotechnology
Ticker: INAB
Sentiment: 0.765
MarketCap: 41,252,820.0
High: 1.01 Low: 0.95

Open: 0.98 Close: 0.98 Change: 0.0

Read more →
...
February 19, 2024 21:16 (London Time)

IN8bio

IN8bio, inc. (inab) stock price, quote & news - stock analysis. IN8abio announces publication on novel gamma-delta t cell therapy.
Sector: Biotechnology
Ticker: INAB
Sentiment: 0.6369
MarketCap: 47,616,057.0
High: 1.15 Low: 1.08

Open: 1.15 Close: 1.11 Change: -0.04

Read more →
Search
Happening Now
Categories